Literature DB >> 9312125

No tRNA3Lys unwinding in a complex with HIV NCp7.

C J Gregoire1, D Gautheret, E P Loret.   

Abstract

The nucleocapsid protein NCp7 of the human immunodeficiency virus (HIV) type 1 is important for the annealing of HIV RNA and tRNA3Lys, the tRNA acting as a primer during reverse transcription of HIV RNA. A wild type NCp7 and a Cys23 mutant having a disrupted zinc finger were analyzed with far UV circular dichroism (CD). CD data analysis revealed that NCp7 has a high content of extended structures in aqueous buffer, decreasing in Cys23 NCp7 and in NCp7 in the absence of zinc. An increase in beta-turn structures is observed in NCp7 bound to tRNA3Lys. Furthermore, CD data shows that Cys23 NCp7 binds tRNA3Lys. The CD spectrum of tRNA3Lys is typical of an A-form helix and retains this structure after binding of NCp7, which demonstrates that NCp7 does not induce tRNA3Lys unwinding. CD spectra of tRNA3Lys were measured from 5 to 80 degrees C to observe CD changes resulting from tRNA3Lys melting. Molecular modeling of the complex identifies two potential tRNA anticodon binding sites in the NCp7 N-terminal region and first zinc finger. In this model, both binding sites can interact with 12 nucleotides in the anticodon domain without requiring a base specificity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9312125     DOI: 10.1074/jbc.272.40.25143

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Rotational dynamics of HIV-1 nucleocapsid protein NCp7 as probed by a spin label attached by peptide synthesis.

Authors:  Zhiwen Zhang; Xiangmei Xi; Charles P Scholes; Christine B Karim
Journal:  Biopolymers       Date:  2008-12       Impact factor: 2.505

2.  Intra-tRNA distance measurements for nucleocapsid proteindependent tRNA unwinding during priming of HIV reverse transcription.

Authors:  B Chan; K Weidemaier; W T Yip; P F Barbara; K Musier-Forsyth
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

3.  Identification of critical elements in the tRNA acceptor stem and T(Psi)C loop necessary for human immunodeficiency virus type 1 infectivity.

Authors:  Q Yu; C D Morrow
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

4.  Functional recognition of the modified human tRNALys3(UUU) anticodon domain by HIV's nucleocapsid protein and a peptide mimic.

Authors:  William D Graham; Lise Barley-Maloney; Caren J Stark; Amarpreet Kaur; Christina Stolarchuk; Khrystyna Stolyarchuk; Brian Sproat; Grazyna Leszczynska; Andrzej Malkiewicz; Nedal Safwat; Piotr Mucha; Richard Guenther; Paul F Agris
Journal:  J Mol Biol       Date:  2011-07-22       Impact factor: 5.469

5.  Human immunodeficiency virus type 1 nucleocapsid protein can prevent self-priming of minus-strand strong stop DNA by promoting the annealing of short oligonucleotides to hairpin sequences.

Authors:  M D Driscoll; S H Hughes
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

6.  Conformational change of single-stranded RNAs induced by liposome binding.

Authors:  Keishi Suga; Tomoyuki Tanabe; Hibiki Tomita; Toshinori Shimanouchi; Hiroshi Umakoshi
Journal:  Nucleic Acids Res       Date:  2011-07-23       Impact factor: 16.971

7.  Characterizing TDP-43 interaction with its RNA targets.

Authors:  Amit Bhardwaj; Michael P Myers; Emanuele Buratti; Francisco E Baralle
Journal:  Nucleic Acids Res       Date:  2013-03-21       Impact factor: 16.971

8.  Thermodynamic studies of a series of homologous HIV-1 TAR RNA ligands reveal that loose binders are stronger Tat competitors than tight ones.

Authors:  Lise Pascale; Stéphane Azoulay; Audrey Di Giorgio; Laura Zenacker; Marc Gaysinski; Pascal Clayette; Nadia Patino
Journal:  Nucleic Acids Res       Date:  2013-04-19       Impact factor: 16.971

9.  Hydrophobic properties of tRNA with varied conformations evaluated by an aqueous two-phase system.

Authors:  Keishi Suga; Hibiki Tomita; Seishiro Tanaka; Hiroshi Umakoshi
Journal:  Int J Biol Sci       Date:  2012-10-15       Impact factor: 6.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.